Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

190.45 +2.04 (+1.08%)
Streaming Delayed Price Updated: 12:06 PM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
57 58 Next >
News headline image
Top 5 Trending Stocks: Prestige Wealth's IPO, Rivian's Lawsuit, Meta's New Platform, Tesla's Dip, And Biogen's FDA Approval ↗
 
Via Benzinga
News headline image
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
News headline image
What's Going On With Biogen Stock Thursday ↗
Biogen Inc (NASDAQ: BIIB) shares were flat in Thursday's after-hours session after falling marginally by 0.31% to $284.99 during  
Via Benzinga
News headline image
3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True ↗
These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers 
Via InvestorPlace
News headline image
Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment ↗
The FDA is expected to announce Thursday whether it has approved or rejected Biogen's Alzheimer's drug. 
Via Investor's Business Daily
News headline image
How Is The Market Feeling About Biogen? ↗
 
Via Benzinga
News headline image
A Look Into Biogen Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Does This Signal Trouble for Biogen's New Alzheimer's Drug? ↗
Biogen is counting on Leqembi to boost its revenue growth. 
Via The Motley Fool
News headline image
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment ↗
Biogen Inc (NASDAQ: BIIB) announced new Spinraza (nusinersen) data that were presented at the SMA Research & Clinical Care Meeting  
Via Benzinga
News headline image
New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene Therapy
From Biogen Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Amgen Inc. Dividend Stock Analysis ↗
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years. 
Via Talk Markets
News headline image
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month? ↗
The catalyst many Biogen investors have been waiting for may soon arrive. 
Via The Motley Fool
News headline image
Alleged Industrial Espionage Makes an Interesting Story ↗
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
News headline image
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies ↗
 
Via Benzinga
News headline image
How to Retire Rich: Biotech Stocks Edition ↗
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks. 
Via InvestorPlace
News headline image
2 Market-Beating Stocks With Major Catalysts on the Way ↗
Can these companies keep climbing? 
Via The Motley Fool
News headline image
7 Undervalued S&P 500 Stocks to Buy in June ↗
If you want to maximize your upside potential in a relatively predictable arena, these undervalued S&P 500 stocks could be for you. 
Via InvestorPlace
News headline image
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed ↗
Senator Bernie Sanders vowed to oppose President Joe Biden's nominated candidate, Monica Bertagnolli, or any other current or future health agency nominee, to lead the National Institutes of Health... 
Via Benzinga
News headline image
Why Biogen Stock Is Trading Down Today ↗
Biogen Inc. (NASDAQ: BIIB) shares fell Tuesday after it was deemed that the ability of the company's Alzheimer's drug, Leqembi, to slow cognitive decline may not outweigh its risks, according to... 
Via Benzinga
News headline image
Methode Electronics, Brookfield Renewable Partners And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources ↗
Experts in Europe considering the potential use of a new Alzheimer's disease drug developed by Eisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) say Leqembi (lecanemab)'s ability to slow 
Via Benzinga
News headline image
Biogen Announces Changes to Its Board of Directors
From Biogen Inc.
Via GlobeNewswire
News headline image
Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground ↗
For the bull run to continue we need broader market participation from SMID caps. 
Via Talk Markets
News headline image
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote ↗
Friday, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted unanimously that the data from Eisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) Phase 3 Clarity AD tria 
Via Benzinga
News headline image
Why Are Cruise Stocks CCL, RCL, NCLH Up Today? ↗
Cruise stocks are on the rise Monday as investors react to a positive note to clients from JPMorgan analysts and we've got the details! 
Via InvestorPlace
News headline image
BIIB Stock Alert: Biogen Resumes Trading With New FDA Backing ↗
Biogen (BIIB) stock is a hot topic among traders Monday as the company's share resumed trading following a halt that was in effect on Friday. 
Via InvestorPlace
News headline image
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low ↗
 
Via Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.